Denmark First European Country to Support Aeras TB Vaccine Efforts

Denmark became the first European country to support the Aeras Global TB Vaccine Foundation's efforts to develop a safe, effective tuberculosis vaccine with announcements of new financial commitments and scientific partnerships. The agreements, announced today in Copenhagen at an update on TB vaccine development, strengthen Denmark's continuing role in the fight against TB. Danida, the Danish development agency, will invest DKK 4.5 million (US$785,000) from its Public Private Partnerships programme to fund the development of a vaccine trial site in South Africa undertaken by Aeras in cooperation with Medicon A/S.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/04-27-2005/0003488848&EDATE=)